RECRUITING

Ultrasound for Healthy Aging

Conditions

Aging Ultrasound Muscle function Cognitive function

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators will study the effects of an ultrasound bath device that uses low-frequency ultrasound on the healthy aging. Participants will have before and after ultrasound assessments of muscle and thinking skills, aging related to the immune system, and body make-up. The group that is assigned to get the ultrasound will have low-frequency ultrasound in a bathtub for 45 minutes, three times weekly for 8 weeks, and the control group will be in the bathtub without the ultrasound turned on.

Official Title

Effects of Ultrasound on Healthy Aging

Quick Facts

Study Start:2025-10-01

Study Completion:2026-12-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT07168525

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:70 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. Males and females; Age 70 or older 2. BMI \<40 kg/m2 3. Ability to walk up a flight of stairs and short ladder 4. Ability to get in and out of a bath 5. Willingness to adhere to the spa treatments regimen	1. To accommodate the participants comfortably in our spa, participants with body weight \>350 pounds, body girth ≥ 50 inches and height ≥ 6 feet 8 inches will be excluded. 2. Any medical condition that, in the opinion of the investigator, would place the participant at increased risk for participation. 3. Fecal or urinary incontinence (daily use of depends) 4. Uncontrolled HTN (BP \>180) or unstable vital signs that in the opinion of the investigator would place at increased risk for participation 5. Any clinically significant rash or formation of rashes or open sores, boils, or infected wounds two weeks prior to screening or any time during the study. 6. History of poor wounds healing lower extremity within the past two years 7. Glycated Hemoglobin (Hgb) A1c level \>8.5% 8. Required use of ambulatory assistive devices 9. Laboratory evidence of infection or colonization with multidrug resistant pathogens in the past 90 days 10. History of myocardial infarction (MI), cerebrovascular accident (CVA) within the past year 11. History of prior non-compliance or the presence of history of health condition (drug or alcohol addiction) that would make it difficult for the participant to comply with the study procedures or follow the investor's instructions 12. Unable to complete procedures in visit 1

Inclusion Criteria

Exclusion Criteria

1. Males and females; Age 70 or older
2. BMI \<40 kg/m2
3. Ability to walk up a flight of stairs and short ladder
4. Ability to get in and out of a bath
5. Willingness to adhere to the spa treatments regimen

1. To accommodate the participants comfortably in our spa, participants with body weight \>350 pounds, body girth ≥ 50 inches and height ≥ 6 feet 8 inches will be excluded.
2. Any medical condition that, in the opinion of the investigator, would place the participant at increased risk for participation.
3. Fecal or urinary incontinence (daily use of depends)
4. Uncontrolled HTN (BP \>180) or unstable vital signs that in the opinion of the investigator would place at increased risk for participation
5. Any clinically significant rash or formation of rashes or open sores, boils, or infected wounds two weeks prior to screening or any time during the study.
6. History of poor wounds healing lower extremity within the past two years
7. Glycated Hemoglobin (Hgb) A1c level \>8.5%
8. Required use of ambulatory assistive devices
9. Laboratory evidence of infection or colonization with multidrug resistant pathogens in the past 90 days
10. History of myocardial infarction (MI), cerebrovascular accident (CVA) within the past year
11. History of prior non-compliance or the presence of history of health condition (drug or alcohol addiction) that would make it difficult for the participant to comply with the study procedures or follow the investor's instructions
12. Unable to complete procedures in visit 1

Contacts and Locations

Study Contact

Blake Rasmussen, PhD

CONTACT

210-450-7491

rasmussenb@uthscsa.edu

Tiffany Cortes, MD

CONTACT

210-450-3333

cortest@uthscsa.edu

Principal Investigator

Blake Rasmussen, PhD

PRINCIPAL_INVESTIGATOR

The University of Texas Health Science Center at San Antonio

Study Locations (Sites)

University of Texas Health Science Center at San Antonio

San Antonio, Texas, 78229

United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center at San Antonio

Blake Rasmussen, PhD, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center at San Antonio

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-10-01

Study Completion Date2026-12-31

Study Record Updates

Study Start Date2025-10-01

Study Completion Date2026-12-31

Terms related to this study

Keywords Provided by Researchers

Ultrasound
Muscle function
Cognitive function

Additional Relevant MeSH Terms

Aging